New association between 4-{ 3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy} benzamide and an acetylcholinesterase inhibitor, and pharmaceutical compositions containing it

摘要

599633 Disclosed is a combination therapy of neurodegenerative diseases such as Parkinson’s and Alzheimer’s with 4-{ 3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy} benzamide or a pharmaceutically acceptable addition salt with an acid or base and an acetylcholine inhibitor preferably donepezil, rivastigmine or galantamine